Status:
RECRUITING
Impact of Combined Oral Contraceptive Pills on Migraine
Lead Sponsor:
Kafrelsheikh University
Conditions:
Migraine
Eligibility:
FEMALE
18-55 years
Phase:
PHASE4
Brief Summary
The investigators will assess the effect of combined oral contraceptive pills (COCs) on migraine features and treatment response to allow better interpretation of the exact consequence of hormonal con...
Detailed Description
The investigators will use a questionnaire to detect the migraineur demographic and clinical features (disease duration, attack frequency and duration, pain intensity assessed by visual analogic scale...
Eligibility Criteria
Inclusion
- female migraine patients on COCs or mechanical contraceptive methods, according to the International Classification of Headache Disorders 3rd edition, aged 18-55 years
Exclusion
- Patients with major neurological conditions such as (epilepsy, ischemic or hemorrhagic stroke, multiple sclerosis, mitochondrial diseases, and brain tumors).
- pregnant, lactating, and menopausal patients.
- Patients with any contraindications to ibuprofen or propranolol.
Key Trial Info
Start Date :
July 15 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 30 2025
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT06509503
Start Date
July 15 2024
End Date
July 30 2025
Last Update
October 9 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kafr Elsheikh University Hospital
Kafr ash Shaykh, Egypt, 33511